Raymond Cheong
Director/Board Member at TALIS BIOMEDICAL CORPORATION
Net worth: 565 839 $ as of 2024-05-30
Profile
Raymond Cheong is currently a Director at Madrigal Pharmaceuticals, Inc., Istari Oncology, Inc., Talis Biomedical Corp., and an Independent Director at vTv Therapeutics, Inc. He previously worked as a Director at Talis Biomedical Corp.
Dr. Cheong holds a doctorate degree from The Johns Hopkins University and an undergraduate degree from the University of Maryland.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-21 | 2,396 ( 0.01% ) | 565 839 $ | 2024-05-30 | |
TALIS BIOMEDICAL CORP.
-.--% | 2024-01-30 | 0 ( -.--% ) | - $ | 2024-05-30 |
Raymond Cheong active positions
| Companies | Position | Start |
|---|---|---|
| TALIS BIOMEDICAL CORPORATION | Director/Board Member | 2023-03-09 |
| MADRIGAL PHARMACEUTICALS, INC. | Director/Board Member | 2023-06-14 |
| VTV THERAPEUTICS INC. | Director/Board Member | 2024-02-26 |
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Director/Board Member | 2018-11-30 |
Former positions of Raymond Cheong
| Companies | Position | End |
|---|---|---|
| TALIS BIOMEDICAL CORPORATION | Director/Board Member | 2022-06-09 |
Training of Raymond Cheong
| University of Maryland | Undergraduate Degree |
| The Johns Hopkins University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| TALIS BIOMEDICAL CORPORATION | Health Technology |
| MADRIGAL PHARMACEUTICALS, INC. | Health Technology |
| VTV THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Health Technology |
- Stock Market
- Insiders
- Raymond Cheong
